Jump to content

Latest News

Tuesday 30 April 2013

Bridging the Valley of Death: How the Biomedical Catalyst is helping SME’s to commercialise innovative healthcare solutions

Early last month, the Technology Strategy Board and the Medical Research Council announced an additional £47.2 million in government funding to the Biomedical Catalyst programme. This funding is targeted at innovative businesses providing new approaches to healthcare services. It is specifically aimed at life sciences companies who find it difficult to secure the start up/early stage funding that they need to progress beyond the so called “valley of death”.

Leave a Comment

You must be logged in to post a comment.

Recent News



What Others Say

Design New Graphic